Literature DB >> 30452638

Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease.

Angela J Khera1, Janet W Chase1, Michael Salzberg1, Alexander J V Thompson1, Michael A Kamm1.   

Abstract

BACKGROUND: Patients with inflammatory bowel disease (IBD) often experience functional bowel symptoms despite achieving disease remission. Although behavioral treatment (bowel and pelvic floor muscle retraining) is effective for managing constipation or fecal incontinence in non-IBD patients, there is limited evidence for its efficacy in patients with quiescent inflammatory bowel disease. The aim of this study was to evaluate the outcome of gut-directed behavioral treatment, including pelvic floor muscle training, for symptoms of constipation or fecal incontinence in patients with IBD in disease remission.
METHODS: The outcome of consecutive patients with IBD in remission and symptoms of constipation or fecal incontinence was evaluated. Patients referred to a multidisciplinary gastroenterology clinic underwent gut-directed behavioral treatment, including pelvic floor muscle training. The primary outcome was patient-reported rating of change in symptoms on a 7-point Likert scale at the completion of treatment.
RESULTS: Forty IBD patients (median age, 35 years; 80% female; 24 Crohn's disease [CD], 12 ulcerative colitis [UC], 4 UC with ileoanal pouch) with ongoing symptoms of constipation (55%) or fecal incontinence (45%), despite drug therapy, were included. The median symptom duration at referral was 2 years. Thirty-five (87%) completed treatment with a median of 2 sessions. Improvement of "6 = much better" or "7 = very much better" was reported by 77% (17/22) with fecal incontinence and 83% (15/18) with constipation. Improvement occurred irrespective of IBD diagnosis, previous perianal fistulae, colorectal surgery, presence of an ileoanal pouch, or past obstetric trauma.
CONCLUSIONS: Behavioral treatment effectively improves functional gut symptoms in a large majority of patients who are in IBD disease remission and who have not responded to drug therapy. 10.1093/ibd/izy344_video1 izy344.video1 5968879349001.
© 2018 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  behavioral treatment; biofeedback; constipation; fecal incontinence; inflammatory bowel disease

Mesh:

Year:  2019        PMID: 30452638     DOI: 10.1093/ibd/izy344

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  4 in total

Review 1.  Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors:  Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

2.  Determinants of long-term function and general well-being in patients with an ileoanal pouch.

Authors:  Angela J Khera; Janet W Chase; Michael Salzberg; Alexander J V Thompson; Rodney J Woods; Amy Wilson-O'Brien; Michael A Kamm
Journal:  JGH Open       Date:  2020-11-12

Review 3.  Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?

Authors:  Dipesh H Vasant; Alexander C Ford
Journal:  World J Gastroenterol       Date:  2020-07-14       Impact factor: 5.742

4.  Fecal Incontinence in Inflammatory Bowel Disease.

Authors:  Natasha Kamal; Kiran Motwani; Jennifer Wellington; Uni Wong; Raymond K Cross
Journal:  Crohns Colitis 360       Date:  2021-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.